Stemline Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 06/28/2019   Download
SEC Document
SEC Filing

As described under Item 5.07 of this Current Report on Form 8-K, on June 25, 2019, at the 2019 Annual Meeting of Stockholders (the “Annual Meeting”) of Stemline Therapeutics, Inc. (the “Company”), the Company’s stockholders, upon the recommendation of the Company’s Board of Directors (the “Board”), approved an amendment to the Certificate of Incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of the Company’s common stock by 30,000,000 shares (the “Amendment”).

 

On June 26, 2019, following the Annual Meeting, the Company filed a certificate of amendment (the “Certificate”) giving effect to the Amendment with the Secretary of State of the State of Delaware. The number of authorized shares of the Company’s preferred stock was not affected by the Amendment and remained unchanged at 5,000,000 shares. The Certificate became effective upon filing with the Secretary of State of the State of Delaware.